Arcadia Biosciences, Inc. (NASDAQ:RKDA) recently saw its volume around 0.37 million shares and on average it trades 0.35 million shares a day. The opening price of $0.22, led it to gain 1.62% to reach $0.22 upon the closing bell.Arcadia Biosciences, Inc. (RKDA) Analyst Opinion
Arcadia Biosciences, Inc. has a consensus hold rating from 1 Wall Street analysts, and the number of shares currently sold short amount to at least 2.3% of shares outstanding. The stock sank -31.95% last month and is down -76.2 this year. Wall Street is only getting neutral on the stock, with 0 of analysts who cover RKDA having a buy-equivalent rating. Analysts have placed a $1 price target on Arcadia Biosciences, Inc., suggesting a 354.55% gain from recent close. It’s currently trading about -85.4% below its 52-week high.Arcadia Biosciences, Inc. Earnings Surprise
Arcadia Biosciences, Inc. (RKDA) revenue totaled $1 million up 1.01% from the previous quarter.Arcadia Biosciences, Inc. (NASDAQ:RKDA) Intraday View
This stock (RKDA) is ahead of its 52-week low with 6.83%. Its last month’s stock price volatility remained 13.74% which for the week stands at 12.69%. The share price has moved backward from its 20 days moving average, trading at a distance of -19.05% and stays -37.31% away from its 50 days moving average. Over the last five days, shares have faced -8.21% losses and now is down -62.31% since hitting its 200-day moving average of $0.474. Arcadia Biosciences, Inc. (RKDA) has made its way to a 12-month decline of -82.48%.
Turning to Netlist, Inc. (NASDAQ:NLST), its shares were trading at $0.3 a retreat of $-0.01, on the trading floor. The stock, after opening at $0.31, touched a high of $0.311 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Netlist, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -78.29% from its high of $1.40 to a $22.21 million market value through last close.Netlist, Inc. (NLST) Consensus Price Target
The company’s consensus rating on Reuter’s scale remained unchanged from 1.67 to 1.67 during a month. Analysts set a 12-month price target of $2.17 a share. The target implies a 623.33% spike from where the shares are currently trading. Also, the current price highlights a discount of 900% to analysts’ high consensus price target.Netlist, Inc. (NASDAQ:NLST) Intraday Trading
The counter witnessed a trading volume of 1.86 million shares versus an average volume of 0.55 million shares during last trading session. Its last month’s stock price volatility remained 12.87% which for the week approaches 10.1%. The lowest price the stock reached in the last trading day was $0.29 and compares with the $0.28 52-week low. The stock recovered 8.11% since its low point and has performed -70.21% year-to-date.